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ABSTRACT 
 
Introduction: Assessing central and peripheral nitric oxide (NO) dynamics of the lung provides information on 
the severity and anatomical site of pulmonary inflammation. Several mathematical methods to calculate 
alveolar and bronchial NO parameters have been introduced. Our aim was to compare these methods. 
Methods: The study included 69 healthy adults, 66 healthy children, 73 asbestos-exposed subjects and 72 
subjects with chronic obstructive pulmonary disease (COPD). Exhaled NO was measured at multiple flow rates 
and we used five mathematical methods (Tsoukias & George, Pietropaoli, Condorelli, Högman & Meriläinen, 
and Silkoff) to estimate alveolar and bronchial NO parameters. 
Results: H&M method was less frequently feasible compared to other methods but it had the highest degree of 
agreement with the measured data. The methods were most often feasible in healthy or asbestos-exposed 
adults but distinctly more infrequently in children and adults with COPD, suggesting difficulties in NO 
measurements in these groups. The linear methods (T&G, Pietropaoli) yielded higher alveolar NO 
concentration and lower bronchial NO flux than the two non-linear methods (H&M, Silkoff) and linear method 
with correction for axial back-diffusion of NO (Condorelli). 
Conclusion: In differentiating central and peripheral NO sources we recommend using the linear methods, as 
low flow rates are not needed and the feasibility of the methods is good. If bronchial wall NO concentration 
(CawNO) and diffusing capacity (DawNO) are of interest, non-linear methods are needed and we recommend 
using H&M method as only three flow rates are needed. However, the agreement between the model and 
measured data needs to be checked in real-time to ensure feasibility. If the subject has difficulties with the 
extremely low or high flow rates, we then recommend using the Silkoff method to improve feasibility, but more 
flow rates and measurements are then needed and the agreement between the model and the measured data 
may be poorer. 
 
  
1. Introduction 
 
Measurement of exhaled NO concentration (FENO) is a promising tool to determine inflammation in different 
lung diseases. Currently, we have the best knowledge of asthma. In particular groups, FENO can be used to 
predict treatment responsiveness. For instance, a high FENO in asthma has been found to predict a good 
response to inhaled corticosteroids [1-3]. However, using more than one flow rate in NO measurement permits 
calculating bronchial and alveolar NO independently. This provides more information on the site of 
inflammation. 
 
 The Two-compartment model 
Nikolaos M. Tsoukias and Steven C. George described the NO exchange dynamics of the lungs by the two-
compartment model in 1998 [4]. In the two-compartment model, lungs are divided into two regions: 
expansible alveolar and rigid bronchial regions (Figure 1). Alveolar and bronchial regions are different in gas 
exchange perspective, enabling to calculate the origin of NO using the two-compartment model. The two-
compartment model is capable of explain three experimentally observed features of the NO exchange 
dynamics: 1) holding breath prior to NO measurement creates a peak in FENO, 2) FENO is inversely proportional 
to flow rate, 3) NO elimination rate (VNO) from the lungs is directly proportional to flow rate [5]. 
 
 
 
 Figure 1. Drawing of the two-compartment model. Exhaled NO concentration (FENO) is the sum of alveolar and 
bronchial contributions. The bronchial or airway region’s contribution depends on three flow-independent 
variables: maximum NO flux from the bronchial wall (J’awNO, pl/s), NO concentration of bronchial mucosa 
(CawNO, ppb) and diffusing capacity of NO from the bronchial wall (DawNO, pl/s/ppb). Alveolar contribution 
depends on steady state alveolar NO concentration (CANO, ppb). 
 
 The Trumpet model with axial back-diffusion (TMAD) 
The two-compartment model assumes the conducting airways as an even, cylinder shaped tube, neglecting the 
fact that the bronchial tree branches towards the more distal airways. Condorelli et al. introduced the trumpet 
model of the lungs with correction for axial back-diffusion of NO (TMAD), where the conducting airways are 
considered as trumpet shaped [6]. This takes account the increasing total cross-sectional area and the mucosal 
surface area of the airways as the bronchial tree branches into smaller bronchioles. As the total cross-sectional 
area of the airways increases, the velocity of airflow decreases, especially in the last generations of the 
bronchial tree. The significant decrease in airflow velocity allows axial back-diffusion of NO from the higher NO 
concentration of the conducting region into the respiratory region, according to the NO concentration gradient. 
It has been proposed that neglecting this axial back-diffusion of NO leads to over estimation of CANO and under 
estimation of JawNO. However, this model is recommended to be utilized only in subjects with no obstruction or 
it can lead to overcorrection [7,8]. Some studies have also reported that the TMAD-correction leads to negative 
CANO values [9-11]. 
 
 The flow-independent NO parameters 
The two-compartment model describes alveolar and bronchial regions’ NO exchange dynamics by flow-
independent NO parameters: CANO (steady state NO concentration in the alveolar region) describing the 
alveolar region, CawNO (NO concentration in bronchial mucosa) and DawNO (NO diffusing capacity of the 
bronchial wall) representing the bronchial region. Maximal bronchial NO flux can be calculated as J’awNO = 
DawNO * CawNO and bronchial NO flux as JawNO = DawNO (CawNO - CANO). Once flow-independent parameters are 
determined, the two-compartment model can be used to predict exhaled NO concentration (ppb) in certain 
exhalation flow rate (VE) by exponential function 
 
FENO = CawNO + (CANO – CawNO) * exp(-DawNO/VE)  [4,5,12,13]                  (1) 
 
When VE is large compared to DawNO (VE > ~ 5* DawNO), the exponential function approaches its first-order 
linear approximation (exp(-DawNO/Ve) = 1 – DawNO/VE) [5]. When this approximation is used in equation 1, the 
equation reduces to following 
 
FENO = CANO + (CawNO – CANO)DawNO*
ଵ
୚୉
                                                                                          (2) 
 
Knowing the fact that JawNO = DawNO(CawNO - CANO), equation 2 can be reduced to 
 
FENO = CANO + JawNO*
ଵ
୚୉
                                                                                                                        (3)  
 
When both sides of this equation 3 are multiplied by VE, linear equation of NO elimination rate is derived 
 
VNO = CANO * Ve + JawNO                 (4)
  
 Analytical methods             
There are several techniques to approximate the flow-independent NO parameters based on measurements of 
FENO at multiple flow rates. In this study, we used four different methods which will be introduced herein. 
Tsoukias et al. [14] used linear equation 4 above in assessing CANO and JawNO (Figure 2A). In this method, FENO 
is measured at several high (ш100 ml/s to verify that VE > ~ 5* DawNO) flow rates. VNO is calculated from 
measured FENO and the flow rates used. Then VNO is plotted against flow rate VE and a regression line is set 
between VNO and VE. CANO is obtained from the slope and JawNO from the intercept of the regression line. 
Pietropaoli et al. [12] utilized linear equation 3 to estimate CANO and JawNO (figure 2B). In this method, the 
measured value of FENO at several high (ш100 ml/s) flow rates are plotted against 
ଵ
୚୉
 and a regression line is set 
between FENO and 
ଵ
୚୉
. The intercept is used as an estimate for CANO whereas slope for JawNO. 
 
 
 
Condorelli et al. used the Tsoukias & George method to calculate CANO and JawNO with correction of the axial 
back-diffusion by applying correction factors aറ and bറ in the following equations [6]: 
CANOCondorelli = CANOT&G - * 
ଵ
௔
JawNOT&G                                                                                                    (5) 
JawNOCondorelli = JawNOT&G * b                                                                                                        (6) 
The values of correction factors a and b are dependent on flow rates used in measurements. 
Silkoff et al. [15] utilized a nonlinear regression analysis using equation 1 to determine all three flow-
independent parameters by measuring FENO at several high and low flows (figure 2C). Högman et al. [13,16] 
used a method that combines some of the methods described above (figure 2D). Three flow rates are needed: 
one low, one medium and one high. CANO is estimated as in Tsoukias & George method: a regression line is set 
between VNO and VE at medium and high flow rates, and the slope is used as an estimate of CANO. DawNO is 
obtained using low and medium flow rates with an iterative technique, whereas CawNO is estimated using 
DawNO and CANO obtained earlier. 
 
 
 
 
 
 
 
 
 
 Figure 2. Schematics describing the mathematical methods used. Tsoukias & George A: VNO is plotted against 
flow rate VE and a regression line is set between VNO and VE. CANO is obtained from the slope and JawNO from 
the intercept of the regression line. In Condorelli method, parameters are calculated likewise before applying 
the flow rate dependent correction factors. Pietropaoli B: FENO is plotted against 
ଵ
୚୉
 and a regression line is set 
between FENO and 
ଵ
୚୉
. The intercept is used as an estimate for CANO whereas slope for JawNO. Silkoff C: FENO is 
plotted against VE using all measured flow rates. CawNO is the intercept of the plot. CANO is the limit of FENO 
when VE approaches infinity (FENO = CANO, when VEїь). DawNO describes the steepness of the plot: small 
DawNO makes the plot steeper. The parameters are calculated by fitting the governing equation (Equation 1) to 
the observed data by regression analysis. Högman & Meriläinen D: CANO and JawNO are obtained by using high 
and medium flow rates as in Tsoukias & George method. DawNO is then calculated using JawNO and FENO at low 
and medium flow rates using an iterative technique. CawNO is then calculated by using all previously calculated 
parameters. 
 
 Aims of the study 
It is important to know whether there are significant differences between the existing methods in NO 
parameter estimation. Sometimes the original measurement data does not fit the mathematical equation used 
to estimate the flow-independent NO parameters and the iterative process does not converge or impossible 
results are obtained (i.e. the method is not feasible in that subject). There may also be differences in the 
model´s degree of agreement with the measured data (i.e. what is the difference between measured FENO and 
calculated FENO). Also, the magnitudes of calculated NO parameters may differ between methods and used 
flow rates. In spite of importance in the development of the methods, comparative studies are scarce. 
The aim of the present study was to compare different analytical methods (Tsoukias & George (T&G), 
Pietropaoli, Condorelli, Silkoff and Högman & Meriläinen (H&M)) to calculate NO parameters regarding 1) their 
feasibility (how often the mathematical analysis succeeded and provided results that were not considered as 
outliers or physically impossible), 2) their degree of agreement with measured data (difference between 
calculated and observed FENO value),  3) the magnitude of calculated NO parameters and 4) the effect of the 
used flow rates on the feasibility and calculated NO parameters. 
 
2. Methods 
 Subjects 
In the analysis, we included subjects from several of our previously published studies utilizing FENO 
measurements at multiple flow rates. The groups were 69 healthy adults, 66 healthy children, 72 adults with 
COPD and 73 adult subjects with previous asbestos exposure. The inclusion and exclusion criteria and clinical 
characteristics are previously published [17-19]. In short, subjects with COPD were newly diagnosed with no 
current anti-inflammatory treatment. They had symptoms compatible with COPD, post-bronchodilator 
FEV1/forced vital capacity (FVC) ratio < 0.7, smoking history of at least 20 pack-years, and emphysema on high-
resolution computed tomography (HRCT) of the lungs. The subjects with previous asbestos exposure were non-
smoking males with a history of moderate to severe occupational exposure to asbestos without other known 
respiratory diseases. 
As the sample size in the current study is predetermined by the original studies, we made a post hoc 
calculation of statistical power for the current analysis. We considered differences in NO parameters given by 
the 5 different calculation methods as main outcome. Using repeated measures ANOVA with ɲ-error of 5 %, a 
sample size of 31 subjects is needed to get statistical power of 95 % to detect a difference between the 
methods that is 0.25 times standard deviation (to keep the estimate conservative we estimated correlation 
among repeated measures to be 0.5 and used correction for nonsphericity as 1, G*Power 3.1.7 was used in 
calculations). As nonparametric tests are usually more conservative that parametric tests and as we used 
nonparametric Friedman’s test instead of parametric ANOVA in comparisons, we consider that we have 
sufficient statistical power in each comparison where the number of subjects with successful measurements is 
above forty. 
 
 
 NO measurement 
As previously described [17-19], exhaled NO was measured using Sievers NOA 280 chemiluminescent analyzer 
(Sievers Instruments, Boulder, Colorado, USA) at different flow rates. We outlaid the flow rates of 10, 50, 100, 
200 and 300 ml/s for the healthy children, whereas flow rates of 10, 20, 30, 50, 100, 200, 300 and 400 ml/s 
were used for the adult subjects. At least two successful NO measurements with coefficient of variation (CV) of 
maximum 3 % were performed at each flow rate. The desired flow rates were achieved by letting the subjects 
exhale through a mass flow meter connected to a computer-controlled, adjustable flow restrictor that kept the 
flow rate steady at the desired level. The linearity of VNO at flows ш 100 ml/s was evaluated later in the analysis 
phase and r < 0.95 was used as an exclusion criterion in the linear methods. 
 
 Calculation of NO parameters 
Before performing any calculations, we visually inspected every FENO versus flow rate plot. Plots were 
accommodated by omitting failed measurements (i.e. if FENO at 300 ml/s < FENO at 400 ml/s, flow rate of 400 
ml/s can be discarded as failed measurement) and using nearest successful measurement point if possible. In 
healthy adults, the flow rate of 400 ml/s was excluded 14 times and at least one of the flow rates between 10 
and 30 ml/s were excluded 4 times. The corresponding numbers for previous asbestos exposure group were 9 
and 3 and in the group of COPD patients 13 and 4. Only 2 300 ml/s flow rates were excluded in healthy 
children. If the plot was beyond accommodation, the subject was excluded from the analysis. A total of 15 plots 
were beyond accommodation in COPD patients and 2 in healthy children in linear methods (these were 
considered as visual drop-outs). The failed flow rates were almost exclusively 300 ml/s and 400 ml/s. Five 
different analytical methods were used (T&G, Pietropaoli, Condorelli, Silkoff and H&M) to calculate the NO 
parameters in every subject group (Figure 2). All calculations were performed by using Microsoft Excel 2007. 
 
2.3.1 Linear methods 
In T&G method, VNO was plotted against VE and we used Excel functions “slope” and “intercept” to calculate 
CANO and JawNO, respectively. Exhalation flow rates of 100, 200, 300 and 400 ml/s were used for adults, 
whereas 100, 200, 300 ml/s were used for children. Correlation coefficient between flow rate and VNO was 
calculated by using the correlation function in Excel. In Pietropaoli method, we used the same flow rates as in 
T&G method. FENO was plotted against 
ଵ
୚୉
 and CANO was calculated using the intercept function and JawNO 
with the slope. The correlation coefficient between ଵ
୚୉
and FENO was also calculated. 
In Condorelli method, NO parameter estimates of the T&G method were used. Correction for axial back-
diffusion was then achieved by using the correction factors (a= 1100 ml/s, b=1.6 with flow rates 100 – 400 ml/s 
and a= 840 ml/s, b=1.7 with flow rates 100 – 300 ml/s) as introduced earlier (Equations 5 and 6). Failed 
measurements were excluded from the calculations as previously described. In adult subjects, one failed flow 
rate was allowed to be excluded. In the case of more than one failed flow rate, we excluded the subject. 
2.3.2 Non-linear methods 
In H&M method, we used an Excel calculation sheet made by Pekka Meriläinen, one of the inventors of the 
method. We compared the results using different three flow rate combinations. The best combination of flow 
rates was found to be 10, 100 and 300 ml/s as it yielded relevant results with least outliers. Failed 
measurements were optimized by using the nearest possible flow rate in place of a failed one (e.g. replacing a 
failed 10 ml/s by 20 ml/s or failed 400 ml/s by 300 ml/s). 
In Silkoff method we compared Solver tool in Microsoft Excel 2007 and a commercial regression analysis 
software NLREG (nlreg.com). However, as both were found to function equally well in our purpose, we chose 
the Excel Solver to be used in the analysis. The Silkoff method is based on non-linear regression analysis in 
which observational data are modeled by a non-linear function. The calculated plot is attempted to fit the 
observational data by changing the model’s parameters. We performed the non-linear regression analysis by 
using the least squares algorithm. The sums of the squared residuals of the observed and calculated FENO 
values at different flow rates are minimized by changing the model’s parameters (DawNO, CawNO and CANO). 
This method requires initial starting value for the iteration process. We used the medians of the CANO, CawNO 
and DawNO calculated for healthy adults using the H&M method as an initial starting value. After the iterations, 
the calculated parameter values were set as the new starting values for a new iteration process. The iteration 
cycle was repeated three more times, setting each time the previously obtained parameter values as new 
starting values. The number of iterations within each cycle depended on how quickly the Excel Solver 
converged to a solution with all constrains satisfied (precision = 0.000001, tolerance 5% and convergence 
0.0001). We used all available successful flow rates in calculations. 
 
 Analysis 
2.4.1. Checking the feasibility and excluding outliers 
 After the calculation of the NO parameters with each of the methods, we evaluated the methods’ feasibility in 
parameter estimation and excluded the outliers using the following criteria CANO < 0, CANO > 10, CawNO < 0 or 
CawNO > 1000. The upper limits were set according to previous results [15,17,20-23] and histograms and lower 
limits are based on the fact that negative concentrations are not physically possible. Defining outlier criteria for 
DawNO was not considered necessary as excluding abnormal CANO and CawNO values excluded abnormal DawNO 
and JawNO values as well at the same. This is explained by the fact that CawNO and DawNO are mathematically 
coupled and in cases of extremely low CawNO, DawNO is extremely high, and vice versa. In the linear methods, 
correlation coefficient less than 0.95 was also used as an exclusion criterion. In H&M method there is an 
internal validity check also included. Negative, or otherwise impossible results as well as inferior correlation 
may conclude that the model of NO production of the respiratory system may be inadequate. It may also be 
due to problems in the measurement situation. A Cochran´s Q test was used to assess if the proportion of 
feasibility differed significantly between the methods. If the p-value with Cochran’s Q test was < 0.05, pairwise 
comparison was performed to check which methods differed significantly from one another. IBM SPSS 
Statistics 24 was used in the statistical analysis. 
 
2.4.2. Checking the method’s degree of agreement.  
We evaluated the methods’ degree of agreement with the observational data by calculating absolute values of 
the difference between observed and calculated values of FENO. A flow rate of 100 ml/s was used in the 
comparison of the measured and calculated FENO, since linear methods apply with higher flow rates only and 
this flow rate also did not produce difficulties for most of the subjects. The difference between the methods 
was compared using nonparametric Friedman’s repeated two-way ANOVA. 
 
2.4.3. Comparing the magnitude of NO parameters between the methods.  
After calculating all the NO parameters with all the methods, the distributions of the calculated parameters 
were compared between different methods using nonparametric Friedman’s repeated two-way ANOVA. The 
results are presented as median, inter-quartile range (IQR), minimum and maximum in the tables.  
 
2.4.4. The effect of the used flow rates on the feasibility and NO parameters. 
 We also assessed the effect of used flow rates in parameter estimates. We calculated the NO parameters for 
healthy adults with all flow rates successful (n = 56) using two different methods, linear T&G and non-linear 
H&M. Flow rates of 100, 200 and 300 ml/s; 200, 300 and 400 ml/s; and 100, 200, 300 and 400 ml/s were used 
in T&G method, whereas flow rates of 10, 100 and 400 ml/s; 10, 100 and 300 ml/s; 20, 100 and 400 ml/s; and 
20, 100 and 300 ml/s were used in H&M method, respectively. After calculating the parameters, outliers were 
excluded as previously described. The distributions of the calculated parameters were compared between 
different flow rates using nonparametric Friedman’s repeated two-way ANOVA. 
 
3. Results 
 
Basic demographics of the subjects are introduced in the Table 1. 
Table 1. Basic demographics of the subjects. 
 Healthy adults Healthy children Asbestos exposure COPD 
N 69 66 73 72 
Sex 61 / 8 32 / 34 All males 50 / 22 
Age 63 (63.5 ± 7.4) 9 (9.7 ± 1.6) 65 (64.9 ± 6.6) 58 (58.5 ± 7.6) 
Fev1 % pred. n.a. n.a. 89.0 ( 88.3 ± 14.0) 52.0 ( 53.8 ± 14.81) 
Sex is presented as (males / females) 
Age and Fev1 % pred. are presented as median (mean ± SD) 
 
 Feasibility of the methods 
The median correlation coefficients for linearity of VNO against flow at flow rates ш 100 ml/s were > 0.99 in all 
groups, indicating a good linearity of measurements. We discovered significant differences in the feasibility of 
different methods between subject groups and between the methods (Table 2). Of the different subject 
groups, the feasibility of all methods was best in healthy adults and in adults with asbestos exposure. In healthy 
children, the feasibility was poorer and it was poorest in subjects with COPD. 
When comparing the different methods in each subject group, linear methods tended to yield results slightly 
more often compared to the non-linear ones. In subject groups where the feasibility was lower (children and 
subjects with COPD), H&M method was feasible significantly less frequently than the other methods. 
 
 
 
 
Table 2. Comparison of the feasibility of the mathematical methods in the parameter estimation and reasons for 
excluding outliers. 
 T&G Pietropaoli Condorelli Silkoff H&M 
Healthy Adults      
Total number of subjects 69 69 69 69 69 
Visual estimation drop-out 0 0 0 0 0 
Outliers excluded, total 6 2 8 8 11 
     CANO < 0   2 4  
     CANO > 10      
     CawNO > 1000    4 9 
     r < 0.95 or H&M validity check 6 2 6  2 
Successful results 63* 67 61 61 58 
      
Healthy children      
Total number of subjects 66 66 66 66 66 
Visual estimation drop-out 2 2 2 1 1 
Outliers excluded, total 2 1 3 8 17 
     CANO < 0   1 1  
     CANO > 10      
     CawNO > 1000    7 16 
     r < 0.95 or H&M validity check 2 1 2  1 
Successful results 62H&M 63H&M 61H&M 57H&M 48 
      
Asbestos exposure      
Total number of subjects 73 73 73 73 73 
Visual estimation drop-out 0 0 0 0 0 
Outliers excluded, total 2 0 3 4 7 
     CANO < 0   1   
     CANO > 10      
     CawNO > 1000    4 7 
     r < 0.95 or H&M validity check 2  2   
Successful results 71** 73 70 69 66 
      
COPD      
Total number of subjects 72 72 72 72 72 
Visual estimation drop-out 15 15 15 0 0 
Outliers excluded, total 6 13 6 17 49 
     CANO < 0   1 3  
     CANO > 10 4 3 3   
     CawNO > 1000    14 37 
     r < 0.95 or H&M validity check 2 10 2  12 
Successful results 51H&M 44H&M 51H&M 55H&M 23 
* Overall p-value 0.097, **Overall p-value 0.067, H&M Significant difference against H&M method (p < 0.05) 
 
 Methods’ degree of agreement with measured data 
We evaluated the degree of agreement of the analytical methods with the measured data by calculating the 
absolute values of the differences between measured and calculated FENO values at flow rate 100 ml/s 
(Supplementary Table 1). Overall among the linear methods, Condorelli method tended to have a better 
degree of agreement with observational data than T&G from which it is derived as it yielded smaller residuals 
of observed and calculated FENO values. Pietropaoli method seemed to have a better agreement in every 
group except the healthy children than other linear methods. Condorelli method had the same degree of 
agreement as Silkoff in children and COPD patients, whereas Silkoff and T&G methods gave similar residuals to 
each other in every group. H&M and Pietropaoli seemed to have greater degree of agreement with the 
observational data in all groups except the healthy children. The non-linear methods differed from each other 
in every group. Overall, H&M method appeared to have the greatest agreement with observational data. 
 
 Comparing the magnitude of NO parameters between the methods 
We discovered statistically significant differences among the results of the compared analytical methods 
(Figures 3-6 and Supplementary tables 2-5). Generally, there were no significant differences between T&G and 
Pietropaoli. However as might be expected, Condorelli method with axial back-diffusion correction yielded 
lower estimates for CANO and higher estimates for JawNO. Interestingly, Silkoff and Condorelli methods 
produced similar CANO estimates with no significant differences in any group. The other linear methods tended 
to give higher estimates for CANO and lower estimates for JawNO as compared to non-linear methods, but the 
absolute difference was quite small and the differences were not all significant. H&M and Pietropaoli methods 
also yielded similar results occasionally. When comparing the non-linear methods to each other, Silkoff method 
gave higher estimates of DawNO and lower estimates of CawNO as compared to H&M. There were no consistent 
differences in CANO and JawNO between H&M and Silkoff methods. 
 
 Figure 3. Box plot presentation of the NO parameters of healthy adults using different analytical methods. Only 
statistically significant differences are marked. 
  
 Figure 4. Box plot presentation of the NO parameters of healthy children using different analytical methods. Only 
statistically significant differences are marked. 
  
 Figure 5. Box plot presentation of the NO parameters of asbestos exposed subjects using different analytical 
methods. Only statistically significant differences are marked. 
 
  
 Figure 6. Box plot presentation of the NO parameters of COPD patients using different analytical methods. Only 
statistically significant differences are marked. 
 
 Comparing the effect of using different flow rates on feasibility and NO 
parameters 
Different flow rates were compared in healthy adults using T&G and H&M (Figures 7 and 8) and statistically 
significant differences were observed in the parameters. In T&G, there were no differences in feasibility 
between flow rates, but difference was found between all flow rate combinations in both parameter values. 
Correlation coefficients had essentially no differences between different flow rate combinations, possibly due 
to exclusion of all failed measurements. 
In the H&M method flow rates of 20, 100, 300 ml/s and 20, 100, 400 ml/s differed among every parameter, 
whereas flow rates of 10, 100, 400 ml/s and 20, 100, 300 ml/s were the same among every parameter. 
Differences in feasibility were found between flow rates 10, 100, 400 ml/s and 20, 100, 400 ml/s (44 vs 33 
successful results, p = 0.008) and between flow rates 20, 100, 400 ml/s and 10, 100, 300 ml/s (33 vs 48 
successful results, p = 0.000). 
 
 
Figure 7. Box plots of the healthy adults’ NO parameters using different flow rates in T&G method. 
 
 
 
 
 
 Figure 8. Box plots of the healthy adults’ NO parameters using different flow rates in H&M method. Only 
statistically significant differences are marked. 
   
4. Discussion 
 
The feasibility of the four methods to calculate NO parameters and their agreement with measured data varied 
between the methods and between the subject groups. Linear methods and Silkoff method were most 
frequently feasible, whereas H&M had the lowest level of feasibility. However, when feasible, H&M had the 
highest degree of agreement with the data followed by the linear methods (T&G, Pietropaoli and Condorelli). 
The methods were most often feasible in healthy or asbestos-exposed adults but distinctly more infrequently 
in children and adults with COPD. There were also differences in the calculated NO parameters between the 
four methods but the two linear methods (T&G, Pietropaoli) yielded quite similar results as did the two non-
linear methods (H&M, Silkoff). Condorelli method yielded smaller values for CANO and larger values for JawNO 
than other linear methods, as expected, and the CANO estimates were essentially the same between Silkoff and 
Condorlli methods. There is very little previous data comparing these mathematical methods in their feasibility 
and agreement with measured values. 
 
 Clinical relevancy and current standardization of multiple flow NO 
measurements 
FENO measurement at multiple flow rates has several promising clinical applications. For instance, it has been 
noticed to be able to detect inflammation in the smaller airways in asthma [24-26]. Peripheral NO production 
(CANO) may also be useful in detecting other inflammatory diseases such as alveolitis and cystic fibrosis 
[19,20,26-28]. Currently, the clinical relevancy of CawNO and DawNO is pending. Thus, the clinical importance of 
non-linear methods over the linear methods is unclear at the moment, although they provide interesting 
information for research purposes. Potential use for CawNO and DawNO might be for example to tell whether 
elevated FENO is due to inflammation in the airways or change in airway diffusivity of nitric oxide [29,30]. 
DawNO and CawNO might therefore be used in airway diseases as separate measures of tissue remodeling and 
inflammatory activity, respectively. Clinical relevancy of all the NO parameters is unknown especially in COPD 
patients, where different pathophysiological aspects of the disease, such as emphysema, may have opposing 
effects on NO parameters. Also, the parameters should be interpreted cautiously as the current models do not 
take account the possible effect of obstruction. It has been reported that obstruction may lead to over 
correction in Condorelli method (lower CANO and higher JawNO values are obtained) [7,8].  
Currently the predominant problem in FENO measurement at several flow rates is the lack of technical 
standardization. Different studies have used several different analyzers, setups, flow rates and mathematical 
methods, making the comparison of the NO parameters between studies challenging. NO parameters are 
known to vary with different used flow rates [31,32] and it is not known whether results obtained using 
different analyzers yield different estimates for NO-parameters as research has only been done on FENO values 
using single flow rates [33-39]. A recent ERS technical guideline [40] has now for first time given 
recommendations also on the multiple flow rate NO measurements, but many aspects are still not validated 
and not standardized. For instance, repeatability of NO parameters, possible circadian variation and differences 
between distinct NO analyzers require further research. 
 
 Feasibility of the methods and their agreement with measured data 
The linear methods were more often feasible (i.e. the mathematical analysis succeeded and provided results 
that were not considered as outliers) than the non-linear methods. This may be related to more simple 
mathematics and the avoidance of extremely low flow rates that are difficult to some subjects. The drawback 
of linear methods is that neither DawNO nor CawNO can be estimated. However, these parameters have a minor 
clinical significance at the moment but may prove to be important when more knowledge on their clinical 
meaning is gained. The difference between the linear methods was not consistent in feasibility but the 
Pietropaoli method had on average better agreement with the data. 
We found that among the non-linear methods Silkoff method was more often feasible than H&M method. 
H&M method’s strength is that only three flow rates are needed, but on the other hand, this makes the 
method also more vulnerable for measurement errors at any single flow rate. However, H&M method had the 
best agreement with our observational data, suggesting that when it is feasible then the quality of data is high 
and that the better feasibility of the Silkoff method comes with the price of lower agreement with measured 
data in addition to the need for more flow rates.  
Clearly the feasibility of all methods was the poorest in children and especially in subjects with COPD. This is 
probably related to the subjects’ ability to perform reliable FENO measurements at very low and very high flow 
rates that usually are the most difficult ones. Molshatski et al. found that high flow rates were most important 
for estimating CANO, while low flow rates were especially important for estimating DawNO [31]. This finding 
may explain the fact that in our study H&M method yielded most relevant results using 10 ml/s as the lowest 
flow rate, as recommended by Högman and colleagues [13,16]. The extreme flow rates appeared to be 
problematic especially in the group of COPD patients, explaining the inferior feasibility of linear methods and 
H&M method in that group. 
Checking for the agreement between the used model and measured data in real-time might help to ensure the 
quality of the measurements. If the subject was unable to perform very high or low flow rates, Silkoff method 
seemed to be the most feasible. 
Roy et al. [21] have also compared different mathematical methods and found that CANO results are 
significantly model-dependent and median error between calculated and observed data is considerably lower 
in non-linear methods than mixed methods. Eckel et al. compared nine different mathematical methods in 
parameter estimation [41]. They suggested using non-linear least squares model with natural log 
transformation on both sides in parameter estimation. This can be considered as Silkoff method with natural 
log transformation on both sides. In their study, Pietropaoli method yielded the least number of negative CANO 
estimates which is in line with our study where Pietropaoli method yielded least outliers. 
On average, the difference between measured and calculated FENO at 100 ml/s was very low. The difference 
would probably be higher at a lower flow of e.g. 50 ml/s where the relation between VNO and VE is more 
nonlinear and the absolute measured ppb values are higher. However, as the linear models do not apply at 
such low flow rates we decided to use the flow rate of 100 ml/s in assessing methods’ degree of agreement 
with measured data. 
 
 Differences in NO parameters between the methods 
There were some statistically significant differences in the NO parameters between the methods but the 
differences were usually quite small. This is in line with previous reports [21,41]. As there is no gold standard to 
assess the NO parameters it is difficult to say which of the methods yields best estimates. 
The linear methods were quite well in line with each other as were the non-linear methods. The linear methods 
gave higher estimates for CANO and lower estimates for JawNO as compared with non-linear methods, but the 
Condorelli method gave smaller estimates for CANO and higher for JawNO. This is likely explained by the fact 
that the linear methods neglect the axial back-diffusion of NO from the conducting region into the alveolar 
region and our findings support this statement. The fact that the linear approximation of the governing 
equation of the two-compartment model is only an approximation and the relation between VNO and VE in T&G 
method and the relation between FENO and 1/VE in Pietropaoli method is not perfectly linear, may also explain 
our results as this causes a minor overestimation of CANO and underestimation of JawNO [29]. In all subject 
groups Silkoff method gave similar results with the Condorelli method for CANO. Silkoff method yielded lower 
estimates for CawNO and higher estimates for DawNO as compared to H&M. This probably reflects the 
difference in the mathematical procedure how these parameters are solved in each of the methods. 
 Differences in NO parameters obtained using different flow rates 
We found differences in NO parameters obtained using different flow rates. This is in line with previous results 
that NO parameters vary with different used flow rates [31,32]. We found that the choice of flow rates had 
more impact on the results of the linear T&G method than of the non-linear H&M.  
 
 Strengths and limitations 
Our study has several strengths. We had a relatively large sample size, which provided us with statistical power. 
All measurements were performed by using the same NO analyzer within same research center, which possibly 
reduced variation. We had also four distinct subject groups, establishing the comparison of the feasibility of the 
methods in adults and children and healthy and diseased groups. 
However, our study also has weaknesses. Our study included only young children and older adults, lacking 
young adults. According to previous studies, the flow independent NO parameters vary with age and this may 
have affected our results [42]. Roy et al. [21]suggested standardizing the number of used flow rates as it 
significantly affects the NO parameter values. We decided not to standardize our used flow rates as our 
objective was more to determine whether the parameters can be calculated at all by accommodating the plots 
if measurement errors were encountered. However, this finding must be taken account as a possible source of 
error. Another limitation of our study is that we did not have a real-time validity check for the fit between 
measured NO data and the mathematical methods but only a check that repeatable FENO values are obtained 
at each flow rate. A real-time check of the agreement with mathematical models would probably improve the 
feasibility of H&M method especially as it uses only three flows (two flows at a time for each step of the 
mathematical process) and is vulnerable to measurement errors even at one flow. 
 
 Conclusion 
In conclusion, if the interest lies in differentiating central and peripheral NO sources and assessing JawNO and 
CANO, based on the current results we recommend using the linear methods, as low flow rates can be avoided 
and the feasibility of the methods is good. The difference between Tsoukias & George and Pietropaoli methods 
does not seem relevant. However, Condorelli method with correction for axial back-diffusion of NO differed 
from other linear methods and may not be applicable in subjects with obstruction. 
If CawNO and DawNO are of interest, we recommend using H&M method as only three flow rates are needed. 
However, due to its vulnerability, we recommend assessing the agreement between the model and measured 
data in real-time to ensure the quality of measurements, as the extreme flow rates are observed to be 
problematic to some subjects. If the subject has difficulties with the extremely low or high flow rates, we then 
recommend using the Silkoff method to improve feasibility. However, more flow rates and FENO 
measurements are then needed and the agreement between the model and the data may be poorer. 
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7. Supplementary tables 
Supplementary Table 1. Comparison of the methods' degree of agreement with measured data. 
 
Absolute values (ppb) of the difference between 
measured and calculated FENO-values at 100 ml/s 
 
p-values 
 T&G Pietropaoli Condorelli Silkoff H&M 
 Silkoff-
H&M 
Silkoff-
T&G 
Silkoff-
Pietropaoli 
H&M-
T&G 
H&M-
Pietropaoli 
T&G-
Pietropaoli 
      
 T&G-
Condorelli 
Pietropaoli-
Condorelli 
Silkoff-
Condorelli 
H&M-
Condorelli 
  
Healthy adults             
Median 0,42 0,08 0,17 0,49 0,03  0,000 1,000 0,000 0,000 0,164 0,000 
IQR 1. - 3. 0,14 - 0,58 0,03 - 0,13 0,07 - 0,28 0,26 - 1,04 0,01 - 0,05  0,063 0,133 0,000 0,000   
Min 0,00 0,00 0,00 0,02 0,00        
Max 2,02 1,39 1,21 3,52 0,75        
             
Healthy 
children 
            
Median 0,13 0,03 0,08 0,28 0,01  0,000 1,000 0,000 0,000 0,041 0,000 
IQR 1. - 3. 0,07 - 0,23 0,02 - 0,06 0,04 - 0,15 0,09 - 0,46 0,00 - 0,02  0,278 0,022 0,136 0,000   
Min 0,00 0,00 0,00 0,01 0,00        
Max 0,50 0,16 0,37 1,06 0,09        
             
Asbestos 
exposure 
            
Median 0,24 0,06 0,17 0,46 0,02  0,000 0,941 0,000 0,000 0,243 0,000 
IQR 1. - 3. 0,10 - 0,41 0,02 - 0,09 0,07 - 0,28 0,20 - 0,84 0,01 - 0,04  0,735 0,000 0,005 0,000   
Min 0,02 0,00 0,00 0,02 0,00        
Max 0,96 0,20 0,63 5,88 0,16        
             
COPD             
Median 0,18 0,03 0,44 0,37 0,00  0,000 0,219 0,000 0,044 1,000 0,336 
IQR 1. - 3. 0,08 - 0,37 0,01 - 0,08 0,17 - 0,84 0,17 - 0,82 0,01 - 0,02  0,162 0,000 1,000 0,000   
Min 0,00 0,00 0,01 0,03 0,00        
Max 2,25 0,44 6,81 8,36 0,06        
   
 
Supplementary Table 2. Comparison of central and peripheral nitric oxide parameters obtained by using four different mathematical methods in healthy adults. 
 
Healthy Adults Parameter values  p-values 
 T&G Pietropaoli Condorelli Silkoff H&M Silkoff-H&M 
Silkoff-
T&G 
Silkoff-
Pietropaoli 
H&M-
T&G 
H&M-
Pietropaoli 
T&G-
Pietropaoli 
            
      T&G-Condorelli 
Pietropaoli
-
Condorelli 
Silkoff-
Condorelli 
H&M-
Condorelli 
  
 
    
 
      
DawNO (pl/s/ppb)      0,000      
Median    8,31 7,27       
IQR 1. - 3.    5,41 - 12,29 4,01 - 9,03       
Min    0,98 0,51       
Max    28,85 29,44       
            
CawNO (ppb)      0,000      
Median    119,10 152,15       
IQR 1. - 3.    88,12 - 177,36 107,26 - 296,20       
Min    26,95 36,04       
Max    535,91 859,18       
            
CANO (ppb)      0,077 0,000 0,000 0,000 0,001 0,196 
Median 3,02 2,74 2,18 1,82 2,38 0,000 0,000 1,000 0,830   
IQR 1. - 3. 2,46 - 3,88 2,27 - 3,37 1,64 - 3,11 1,11 - 2,53 2,00 - 2,98       
Min 0,98 1,03 0,17 0,06 0,65       
Max 6,16 6,45 5,43 4,77 4,38       
            
JawNO (pl/s)      1,000 0,000 0,000 0,000 0,001 0,532 
Median 806,67 859,08 1270,22 919,37 926,68 0,000 0,000 0,001 0,000   
IQR 1. - 3. 515,00 - 1010,00 583,28 - 1123,69 817,33 - 1602,67 764,97 - 1315,98 726,52 - 1312,12       
Min 155,56 150,00 248,89 240,63 272,85       
Max 3656,67 3517,74 3813,33 4262,83 3850,70       
   
 
Supplementary Table 3.  Comparison of central and peripheral nitric oxide parameters obtained by using four different mathematical methods in healthy children.  
 
  
Healthy children Parameter values  p-values 
 T&G Pietropaoli Condorelli Silkoff H&M Silkoff-H&M 
Silkoff-
T&G 
Silkoff-
Pietropaoli 
H&M-
T&G 
H&M-
Pietropaoli 
T&G-
Pietropaoli  
            
     T&G-Condorelli 
Pietropaoli-
Condorelli 
Silkoff-
Condorelli 
H&M-
Condorelli 
  
 
           
DawNO ( pl/s/ppb)      0,000      
Median    8,56 6,49       
IQR 1. - 3.    4,75 - 14,42 3,48 - 11,67       
Min    0,28 0,86       
Max    35,47 27,14        
           
CawNO (ppb)      0,000      
Median    53,60 57,28       
IQR 1. - 3.    34,53 - 103,43 40,83 - 131,78       
Min    15,01 17,91       
Max    596,29 727,88        
           
CANO (ppb)      0,000 0,000 0,000 0,007 1,000 0,002 
Median 2,18 2,16 1,85 1,70 2,13 0,000 0,000 1,000 0,000   
IQR 1. - 3. 1,90 - 2,89 1,84 - 2,66 1,56 - 2,53 1,30 - 2,28 1,79 - 2,50       
Min 0,90 0,96 0,80 0,58 0,41       
Max 4,45 4,74 3,53 3,59 4,36        
           
JawNO (pl/s)      0,034 0,000 0,000 0,000 0,532 0,278 
Median 336,67 378,46 533,33 445,66 449,84 0,000 0,000 0,014 0,000   
IQR 1. - 3. 246,67 - 580,00 275,77 - 602,31 394,67 - 928,00 326,98 - 682,70 301,48 - 651,88       
Min 80,00 71,54 128,00 164,52 122,38       
Max 1386,67 1375,38 1610,67 1227,00 1597,65       
   
 
Supplementary Table 4. Comparison of central and peripheral nitric oxide parameters obtained by using four different methods in subjects with a previous asbestos exposure. 
 
 
 
Asbestos exposure Parameter values  p-values 
 T&G Pietropaoli Condorelli Silkoff H&M Silkoff-H&M 
Silkoff-
T&G 
Silkoff-
Pietropaoli 
H&M-
T&G 
H&M-
Pietropaoli 
T&G-
Pietropaoli  
            
     T&G-Condorelli 
Pietropaoli-
Condorelli 
Silkoff-
Condorelli 
H&M-
Condorelli 
  
     
 
      
DawNO ( pl/s/ppb)      0,000      
Median    9,87 7,88       
IQR 1. - 3.    6,36 - 14,58 4,37 - 12,88       
Min    0,85 1,05       
Max    69,47 57,25        
           
CawNO (ppb)      0,000      
Median    88,66 101,21       
IQR 1. - 3.    54,05 - 155,00 62,85 - 178,45       
Min    18,71 17,41       
Max    392,88 773,61        
           
CANO (ppb)      0,130 0,000 0,000 0,000 0,032 0,047 
Median 2,71 2,57 2,15 1,77 2,25 0,000 0,000 1,000 0,003   
IQR 1. - 3. 2,06 - 3,47 1,91 - 3,09 1,46 - 2,85 1,17 - 2,59 1,64 - 2,92       
Min 0,73 0,76 0,37 0,26 0,57       
Max 5,84 5,67 5,17 6,57 6,24        
           
JawNO (pl/s)      1,000 0,000 0,000 0,000 0,000 0,209 
Median 623,33 675,08 997,33 823,93 766,53 0,000 0,000 0,000 0,000   
IQR 1. - 3. 418,89 - 890,56 455,38 - 903,08 697,56 - 1464,00 601,31 - 1104,46 602,97 - 1085,62       
Min 186,67 229,74 298,67 283,53 250,63       
Max 1936,67 1955,90 3098,67 2729,35 2317,39       
   
 
 
Supplementary Table 5. Comparison of central and peripheral nitric oxide parameters obtained by using four different methods in subjects with COPD. 
 
 
COPD Parameter values  p-values 
 T&G Pietropaoli Condorelli Silkoff H&M Silkoff-H&M 
Silkoff-
T&G 
Silkoff-
Pietropaoli 
H&M-
T&G 
H&M-
Pietropaoli 
T&G-
Pietropaoli 
            
      T&G-Condorelli 
Pietropaoli-
Condorelli 
Silkoff-
Condorelli 
H&M-
Condorelli 
  
            
DawNO ( pl/s/ppb)      0,011      
Median    5,41 3,09       
IQR 1. - 3.    3,02 - 10,77 1,70 - 13,16       
Min    0,62 0,47       
Max    41,88 58,59       
            
CawNO (ppb)      0,011      
Median    64,68 101,82       
IQR 1. - 3.    32,22 - 194,33 34,47 - 314,42       
Min    6,36 5,95       
Max    858,49 931,30       
            
CANO (ppb)      1,000 0,000 0,003 0,000 0,006 1,000 
Median 3,04 3,20 2,85 1,85 2,23 0,162 1,000 0,139 0,253   
IQR 1. - 3. 2,39 - 4,01 2,22 - 4,00 2,21 - 4,02 1,31 - 2,51 1,48 - 2,71       
Min 1,40 1,50 1,08 0,18 0,70       
Max 8,32 8,73 9,53 7,83 6,46       
            
JawNO (pl/s)      0,442 0,000 0,002 0,062 0,831 1,000 
Median 333,33 368,46 396,67 386,21 400,42 0,000 0,000 1,000 0,139   
IQR 1. - 3. 145,56 - 416,11 266,85 - 480,92 181,50 - 656,00 222,54 - 612,14 224,03 - 629,95       
Min -100,00 46,15 -170,00 76,83 81,98       
Max 2113,33 2220,72 3381,33 4218,63 2462,62       
